Supplementary FIgure S4 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
<p>Effects of modulating CD99 and ILK1 in DMG cells as measured using western blotting and cell proliferation. Dosing curves of ILK1 inhibitor, Cpd22, on CD99 altered cell lines as measured by MTS assay.</p>
Authors
- Rajeev Vibhakar (ORCID: https://orcid.org/0000-0002-5949-3896)
- Breauna Brunt
- Bridget Sanford (ORCID: https://orcid.org/0000-0002-2173-0198)
- Ammu Suresh (ORCID: https://orcid.org/0000-0001-6035-7501)
- Krishna Madhavan (ORCID: https://orcid.org/0000-0002-1234-413X)
- Senthilnath Lakshmanachetty (ORCID: https://orcid.org/0000-0002-3760-2772)
- Ilango Balakrishnan (ORCID: https://orcid.org/0000-0002-8876-6144)
- Sujatha Venkataraman (ORCID: https://orcid.org/0000-0002-1512-284X)
- Adam L. Green (ORCID: https://orcid.org/0000-0002-4469-2358)
- Etienne Danis (ORCID: https://orcid.org/0000-0002-5651-8111)
- Angela Pierce (ORCID: https://orcid.org/0000-0003-0848-0494)
- Siddhartha S. Mitra (ORCID: https://orcid.org/0000-0002-1829-7856)
- Nathan Davidson
- Nathan Dahl (ORCID: https://orcid.org/0000-0003-2555-1741)
- John DeSisto (ORCID: https://orcid.org/0000-0003-1058-4604)
- Faye Walker (ORCID: https://orcid.org/0000-0002-9166-6961)
- Zachary James Nuss
- Andrew M. Donson (ORCID: https://orcid.org/0000-0003-1153-6911)
- Joshua Michlin
- Dong Wang (ORCID: https://orcid.org/0009-0005-5701-9532)
- Kenneth L. Jones
Publication Details
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1158/0008-5472.29918873
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00